Stock Events

Stock Events

Actuate Therapeutics (ACTU) Q4 2025 Earnings

13NovConfirmed

Q1 2025

Q2 2025

Q3 2025

Q4 2025

-0.33

-0.3

-0.28

-0.25

Details

Expected EPS

-0.263333

Actual EPS

-0.25

Surprise EPS

0.01

Surprise Percent

+5.06%

Description

Actuate Therapeutics (ACTU) has reported earnings of -0.25 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.